MedCap AB (publ) (STO:MCAP)
504.50
+21.70 (4.49%)
Apr 14, 2026, 5:29 PM CET
MedCap AB Revenue
In the year 2025, MedCap AB had annual revenue of 2.15B SEK with 15.91% growth. MedCap AB had revenue of 607.40M in the quarter ending December 31, 2025, with 25.01% growth.
Revenue (ttm)
2.15B
Revenue Growth
+15.90%
P/S Ratio
3.59
Revenue / Employee
3.31M
Employees
627
Market Cap
7.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.15B | 295.20M | 15.91% |
| Dec 31, 2024 | 1.86B | 241.20M | 14.94% |
| Dec 31, 2023 | 1.61B | 460.40M | 39.89% |
| Dec 31, 2022 | 1.15B | 204.50M | 21.54% |
| Dec 31, 2021 | 949.60M | 105.30M | 12.47% |
| Dec 31, 2020 | 844.30M | 73.00M | 9.46% |
| Dec 31, 2019 | 771.30M | 57.50M | 8.06% |
| Dec 31, 2018 | 713.80M | 113.90M | 18.99% |
| Dec 31, 2017 | 599.90M | -259.50M | -30.20% |
| Apr 30, 2017 | 859.40M | 31.12M | 3.76% |
| Apr 30, 2016 | 828.29M | -35.66M | -4.13% |
| Apr 30, 2015 | 863.95M | 31.36M | 3.77% |
| Apr 30, 2014 | 832.59M | 474.96M | 132.81% |
| Apr 30, 2013 | 357.63M | 46.99M | 15.13% |
| Apr 30, 2012 | 310.64M | -7.27M | -2.29% |
| Apr 30, 2011 | 317.91M | 58.45M | 22.53% |
| Apr 30, 2010 | 259.46M | 70.85M | 37.56% |
| Apr 30, 2009 | 188.61M | -1.41M | -0.74% |
| Apr 30, 2008 | 190.02M | 101.07M | 113.62% |
| Apr 30, 2007 | 88.95M | 77.98M | 710.70% |
| Dec 31, 2005 | 10.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Elekta AB | 17.11B |
| Nolato AB | 9.46B |
| Sectra AB | 3.52B |
| Vitrolife AB | 3.44B |
| BICO Group AB | 1.50B |
| Xvivo Perfusion AB | 812.17M |
| CellaVision AB | 758.97M |
MedCap AB News
- 2 months ago - What To Expect From MedCap AB (OSTO:MCAP) Q4 2025 Earnings - GuruFocus